In TNBC mouse models, studies have found glycolysis inhibits the expression of granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage colony-stimulating factor (GM-CSF) resulting in the decreased expression of MDSCs and promotion of tumor immunosuppression (80). Here, CSF2 is linked to neoplasm.